8 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 10 Not applicable, 3 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.
Follow Drinking Water: new trials by email Literature Review of Drinking Water trials Research Report on Drinking Water
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial. intestinal fluid infusion, potable water - Low Anterior Resection Syndrome, Rectal Cancer | Phase 2 / Phase 3 | Recruiting | Pei-Rong Ding | 160 | 2026-04-10 | 2026-04-17 |
| Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy Premedication with n-acetylcysteine, Placebo (drinking water), Premedication with simethicone - Esophagogastroduodenoscopy, Simethicone | Phase 2 | Recruiting | Hospital General de Mexicali | 132 | 2025-09-12 | 2025-11-24 |
| Comparison Between Drinking Water and Normal Saline in Irrigating Traumatic Wound Irrigating Traumatic Wound with Drinking Water - Trauma | Not applicable | Not yet recruiting | Patan Academy of Health Sciences | 440 | 2024-03-01 | 2024-03-12 |
| Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries Drinking water, Apple juice - Caries, Metabolomic Profile | Not applicable | Completed | Jodi Stookey | 105 | 2022-10-12 | 2026-02-25 |
| Photodegraded Edible Food Dyes Erythrosine, prepared in drinking water (0.69 mg/kg bw/day), SODIS-treated erythrosine, prepared in drinking water (0.69 mg/kg bw/day), Iodine, prepared in drinking water 0.075 mg/kg bw/day) - Thyroid; Functional Disturbance | Not applicable | Withdrawn | Yale University | 2022-09-01 | 2022-11-01 | |
| Effects of Aromatic Solution Applied After Surgery group treated with aromatic solution, group treated with drinking water - Surgery, Nurse's Role | Not applicable | Completed | Cukurova University | 110 | 2021-02-15 | 2026-10-21 |
| Coffee After Pancreatic Surgery Standard coffee, Caffeine-free coffee, Drinking water - Postoperative Ileus, Postoperative Complications | Not applicable | Completed | Azienda Ospedaliera Universitaria Integrata Verona | 204 | 2020-01-05 | 2026-06-08 |
| The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy water as bladder distending media, intravenous dye, No intervention - Hysterectomy, Cystoscopy | Not applicable | Completed | WellSpan Health | 276 | 2018-07-01 | 2023-03-17 |
| Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients. Nanotechnology structured water ( Magnalife), ordinary water - Type2 Diabetes | Not applicable | Completed | ALI KAMAL M. SAMI | 387 | 2016-07-03 | 2019-09-10 |
| Water and Sudafed in Autonomic Failure Pseudoephedrine + 480 ml water, Pseudoephedrine + 50 ml water, Placebo + 480 ml water (optional) - Shy-Drager Syndrome, Multiple System Atrophy | Early Phase 1 | Terminated | Vanderbilt University | 35 | 2014-10-01 | 2021-05-05 |
| Dehydration, Rehydration, and Blood Viscosity Essentia Water, Bottled water - Dehydration | Not applicable | Completed | Essentia Water, LLC | 100 | 2014-04-01 | 2014-07-16 |
| Effect of Mouth Rinses in Oral Malodor Fluoride rinse, Halita, Meridol Halitosis - Halitosis | Not applicable | Unknown | Universitaire Ziekenhuizen KU Leuven | 96 | 2013-03-01 | 2012-12-11 |
| A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects GR181413A/AT1001 solution, GR181413A/AT1001 capsule, Potable water - Fabry Disease | Phase 1 | Completed | Amicus Therapeutics | 14 | 2011-09-01 | 2013-12-18 |
| Effects of Free Water Protocol on Inpatients in a Neurological Rehabilitation Setting Water - Dysphagia | Not applicable | Completed | University of Manitoba | 30 | 2010-08-01 | 2013-08-09 |
| Treatment of Orthostatic Intolerance Acetazolamide, Atomoxetine, NO Drug - Tachycardia, Chronic Orthostatic Intolerance | Phase 1 / Phase 2 | Active not recruiting | Satish R. Raj | 150 | 1997-04-01 | 2026-10-16 |
Deglutition Disorders (1) · Dehydration (1) · Diabetes Mellitus, Type 2 (1) · Fabry Disease (1) · Halitosis (1) · Intestinal Diseases (1) · Low Anterior Resection Syndrome (1) · Motor Activity (1) · Multiple System Atrophy (1) · Pancreatic Diseases (1) · Pharyngitis (1) · Postoperative Complications (1) · Postoperative Nausea and Vomiting (1) · Postural Orthostatic Tachycardia Syndrome (1) · Pure Autonomic Failure (1)
ALI KAMAL M. SAMI (1) · Amicus Therapeutics (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Cukurova University (1) · Essentia Water, LLC (1) · Hospital General de Mexicali (1) · Jodi Stookey (1) · Patan Academy of Health Sciences (1) · Pei-Rong Ding (1) · Satish R. Raj (1) · Universitaire Ziekenhuizen KU Leuven (1) · University of Manitoba (1) · Vanderbilt University (1) · WellSpan Health (1) · Yale University (1)
United States (6) · Australia (1) · Belgium (1) · Canada (1) · China (1) · Italy (1) · Mexico (1) · Turkey (Türkiye) (1)
Ali K M.Sami, Ph.D. (1) · Ashis Shrestha, Fellow (1) · Emily M Garland, PhD, MSCI (1) · Giuseppe Malleo, MD PhD (1) · Gregory Fridman, PhD (1) · Jodi Stookey, PhD (1) · Marc Quirynen, PhD, DDS (1) · Mimansa Cholera, DDS (1) · Okechukwu Ibeanu, MD (1) · Satish R Raj, MD MSCI (1) · Sepideh Pooyania, MD. FRCPC (1) · Thomas Tanbonliong, DDS (1)
PMID 15911704, PMID 19687359, PMID 24002370, PMID 24227635, PMID 24325147, PMID 24495468, PMID 24606242, PMID 24721800, PMID 27536442, PMID 29971260, PMID 31044749, PMID 32016519, PMID 32673517, PMID 39644858
UL1TR000445 (2), P01HL056693 (1)